{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:16:50Z","timestamp":1789175810126,"version":"build-2803163510"},"reference-count":139,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hainan Province Clinical Medical Center","award":["2021818"],"award-info":[{"award-number":["2021818"]}]},{"name":"The specific research fund of The Innovation Platform for Academicians of Hainan Province","award":["YSPTZX202313"],"award-info":[{"award-number":["YSPTZX202313"]}]},{"name":"Hainan Provincial Health Industry Research Project","award":["22A200078"],"award-info":[{"award-number":["22A200078"]}]},{"name":"Hainan Provincial Postgraduate Innovation Research Project","award":["Qhyb2022-133"],"award-info":[{"award-number":["Qhyb2022-133"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,24]]},"abstract":"<jats:p>Inflammatory bowel disease is a chronic inflammatory condition predominantly affecting the intestines, encompassing both ulcerative colitis and Crohn disease (CD). As one of the most common gastrointestinal disorders, CD\u2019s pathogenesis is closely linked with the intestinal microbiota. Recently, fecal microbiota transplantation (FMT) has gained attention as a potential treatment for CD, with the effective reestablishment of intestinal microecology considered a crucial mechanism of FMT therapy. This article synthesizes the findings of population-based cohort studies to enhance our understanding of gut microbial characteristics in patients with CD. It delves into the roles of \u201cbeneficial\u201d and \u201cpathogenic\u201d bacteria in CD\u2019s development. This article systematically reviews and compares data on clinical response rates, remission rates, adverse events, and shifts in bacterial microbiota. Among these studies, gut microbiome analysis was conducted in only 7, and a single study examined the metabolome. Overall, FMT has demonstrated a partial restoration of typical CD-associated microbiological alterations, leading to increased \u03b1-diversity in responders and a moderate shift in patient microbiota toward the donor profile. Several factors, including donor selection, delivery route, microbial state (fresh or frozen), and recipient condition, are identified as pivotal in influencing FMT\u2019s effectiveness. Future prospective clinical studies with larger patient cohorts and improved methodologies are imperative. In addition, standardization of FMT procedures, coupled with advanced genomic techniques such as macroproteomics and culture genomics, is necessary. These advancements will further clarify the bacterial microbiota alterations that significantly contribute to FMT\u2019s therapeutic effects in CD treatment, as well as elucidate the underlying mechanisms of action.<\/jats:p>","DOI":"10.1097\/md.0000000000041262","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:00:50Z","timestamp":1737759650000},"page":"e41262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review"],"prefix":"10.1097","volume":"104","author":[{"given":"Shiju","family":"Chen","sequence":"first","affiliation":[{"name":"Graduate School, Hainan Medical University, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya","family":"Zhang","sequence":"additional","affiliation":[{"name":"Graduate School, Hainan Medical University, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate School, Hainan Medical University, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Graduate School, Hainan Medical University, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Graduate School, Hainan Medical University, Haikou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-1921","authenticated-orcid":false,"given":"Feihu","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China"},{"name":"The Gastroenterology Clinical Medical Center of Hainan Province, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250124","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.cgh.2022.06.030","article-title":"Global hospitalization trends for Crohn\u2019s disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses.","volume":"21","author":"Buie","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-20250124","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20250124","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/ajg.2012.251","article-title":"Should we standardize the 1,700-year-old fecal microbiota transplantation.","volume":"107","author":"Zhang","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R4-20250124","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","article-title":"Microbiota transplantation: concept, methodology and strategy for its modernization.","volume":"9","author":"Zhang","year":"2018","journal-title":"Protein Cell"},{"key":"R5-20250124","first-page":"1927","article-title":"Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases.","volume":"135","author":"Wang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"R6-20250124","doi-asserted-by":"crossref","first-page":"e29790","DOI":"10.1097\/MD.0000000000029790","article-title":"An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis.","volume":"101","author":"Huang","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R7-20250124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00384-023-04354-4","article-title":"Fecal microbiota transplantation for induction of remission in Crohn\u2019s disease: a systematic review and meta-analysis.","volume":"38","author":"Zhou","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"R8-20250124","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3748\/wjg.v29.i20.3185","article-title":"Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.","volume":"29","author":"Halkjaer","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R9-20250124","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.3390\/biomedicines11112930","article-title":"Fecal microbiota transplantation in liver cirrhosis.","volume":"11","author":"Boicean","year":"2023","journal-title":"Biomedicines"},{"key":"R10-20250124","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial.","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"R11-20250124","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"R12-20250124","doi-asserted-by":"crossref","first-page":"106791","DOI":"10.1016\/j.clineuro.2021.106791","article-title":"Fecal microbiota transplant as a potential treatment for Parkinson\u2019s disease - a case series.","volume":"207","author":"Segal","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"R13-20250124","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s42000-020-00265-z","article-title":"Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity.","volume":"20","author":"Allegretti","year":"2021","journal-title":"Hormones (Athens)"},{"key":"R14-20250124","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.radonc.2020.01.011","article-title":"Fecal microbiota transplantation: a promising treatment for radiation enteritis?","volume":"143","author":"Ding","year":"2020","journal-title":"Radiother Oncol"},{"key":"R15-20250124","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/microorganisms11020387","article-title":"Controversies in the prevention and treatment of clostridioides difficile infection in adults: a narrative review.","volume":"11","author":"Bainum","year":"2023","journal-title":"Microorganisms"},{"key":"R16-20250124","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41591-018-0238-9","article-title":"Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"R17-20250124","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2015.09.008","article-title":"Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn\u2019s disease.","volume":"18","author":"Lewis","year":"2015","journal-title":"Cell Host Microbe"},{"key":"R18-20250124","doi-asserted-by":"crossref","first-page":"e0170034","DOI":"10.1371\/journal.pone.0170034","article-title":"Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease.","volume":"12","author":"Vrakas","year":"2017","journal-title":"PLoS One"},{"key":"R19-20250124","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","article-title":"A microbial signature for Crohn\u2019s disease.","volume":"66","author":"Pascal","year":"2017","journal-title":"Gut"},{"key":"R20-20250124","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.21319","article-title":"Dysbiosis of fecal microbiota in Crohn\u2019s disease patients as revealed by a custom phylogenetic microarray.","volume":"16","author":"Kang","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R21-20250124","doi-asserted-by":"crossref","first-page":"626232","DOI":"10.3389\/fped.2021.626232","article-title":"Gut microbiota profile in pediatric patients with inflammatory bowel disease: a systematic review.","volume":"9","author":"Zhuang","year":"2021","journal-title":"Front Pediatr"},{"key":"R22-20250124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.retram.2019.01.002","article-title":"Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction.","volume":"67","author":"Heidarian","year":"2019","journal-title":"Curr Res Transl Med"},{"key":"R23-20250124","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gut.2005.078824","article-title":"Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.","volume":"55","author":"Conte","year":"2006","journal-title":"Gut"},{"key":"R24-20250124","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-017-1384-4","article-title":"Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.","volume":"53","author":"Nishino","year":"2018","journal-title":"J Gastroenterol"},{"key":"R25-20250124","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1111\/1751-7915.14074","article-title":"Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery.","volume":"15","author":"Lu","year":"2022","journal-title":"Microb Biotechnol"},{"key":"R26-20250124","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13073-017-0490-5","article-title":"A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients.","volume":"9","author":"Hall","year":"2017","journal-title":"Genome Med"},{"key":"R27-20250124","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/00365521.2020.1803396","article-title":"Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character).","volume":"55","author":"Vatn","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"R28-20250124","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ecco-jcc\/jjv147","article-title":"Altered fecal microbiota in paediatric inflammatory bowel disease.","volume":"9","author":"Maukonen","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R29-20250124","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/01.mib.0000235828.09305.0c","article-title":"Abnormal microbiota composition in the ileocolonic mucosa of Crohn\u2019s disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis.","volume":"12","author":"Martinez-Medina","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R30-20250124","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/jam.15154","article-title":"Combined analysis of metagenomic data revealed consistent changes of gut microbiome structure and function in inflammatory bowel disease.","volume":"131","author":"Xia","year":"2021","journal-title":"J Appl Microbiol"},{"key":"R31-20250124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease.","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol"},{"key":"R32-20250124","doi-asserted-by":"crossref","first-page":"e61622","DOI":"10.1128\/spectrum.00616-22","article-title":"Dysbiosis in the gut microbiota in patients with inflammatory bowel disease during remission.","volume":"10","author":"Pisani","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R33-20250124","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ecco-jcc\/jjx153","article-title":"Characteristics of faecal microbiota in paediatric Crohn\u2019s disease and their dynamic changes during infliximab therapy.","volume":"12","author":"Wang","year":"2018","journal-title":"J Crohns Colitis"},{"key":"R34-20250124","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.","volume":"67","author":"Imhann","year":"2018","journal-title":"Gut"},{"key":"R35-20250124","doi-asserted-by":"crossref","first-page":"2083419","DOI":"10.1080\/19490976.2022.2083419","article-title":"Gut microbiota in mucosa and feces of newly diagnosed, treatment-naive adult inflammatory bowel disease and irritable bowel syndrome patients.","volume":"14","author":"Cipcic","year":"2022","journal-title":"Gut Microbes"},{"key":"R36-20250124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mayocp.2013.10.011","article-title":"A clinician\u2019s primer on the role of the microbiome in human health and disease.","volume":"89","author":"Khanna","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"R37-20250124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MPG.0000000000002611","article-title":"Altered gut microbiota is present in newly diagnosed pediatric patients with inflammatory bowel disease.","volume":"70","author":"Sila","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R38-20250124","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0971-5916.162091","article-title":"Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.","volume":"142","author":"Kabeerdoss","year":"2015","journal-title":"Indian J Med Res"},{"key":"R39-20250124","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2010.223263","article-title":"Dysbiosis of the faecal microbiota in patients with Crohn\u2019s disease and their unaffected relatives.","volume":"60","author":"Joossens","year":"2011","journal-title":"Gut"},{"key":"R40-20250124","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"R41-20250124","first-page":"46","article-title":"Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.","volume":"30","author":"Cardoneanu","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"R42-20250124","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/MIB.0000000000000776","article-title":"Mucosa-associated ileal microbiota in new-onset pediatric Crohn\u2019s disease.","volume":"22","author":"Assa","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R43-20250124","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/ajg.2012.335","article-title":"Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn\u2019s but not in ulcerative colitis.","volume":"107","author":"Hansen","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R44-20250124","doi-asserted-by":"crossref","first-page":"8941340","DOI":"10.1155\/2018\/8941340","article-title":"Protocol for fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta-analysis.","volume":"2018","author":"Fang","year":"2018","journal-title":"Biomed Res Int"},{"key":"R45-20250124","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/1751-2980.12795","article-title":"Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.","volume":"20","author":"Weng","year":"2019","journal-title":"J Dig Dis"},{"key":"R46-20250124","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/jgh.15598","article-title":"Fecal microbiota transplantation therapy in Crohn\u2019s disease: systematic review.","volume":"36","author":"Fehily","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R47-20250124","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1038\/ajg.2010.281","article-title":"Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.","volume":"105","author":"Png","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R48-20250124","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/ibd.21606","article-title":"Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.","volume":"17","author":"Strauss","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R49-20250124","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.1055\/s-0042-105205","article-title":"Colonic transendoscopic enteral tubing: a novel way of transplanting fecal microbiota.","volume":"4","author":"Peng","year":"2016","journal-title":"Endosc Int Open"},{"key":"R50-20250124","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10151-020-02395-3","article-title":"Fecal microbiota transplantation for Crohn\u2019s disease: a systematic review and meta-analysis.","volume":"25","author":"Cheng","year":"2021","journal-title":"Tech Coloproctol"},{"key":"R51-20250124","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41575-021-00441-5","article-title":"Recipient factors in faecal microbiota transplantation: one stool does not fit all.","volume":"18","author":"Danne","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R52-20250124","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ecco-jcc\/jjv203","article-title":"Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease.","volume":"10","author":"Vermeire","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R53-20250124","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1073\/pnas.1904099116","article-title":"Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn\u2019s disease, produces an inflammatory polysaccharide.","volume":"116","author":"Henke","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54-20250124","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.csbj.2023.05.010","article-title":"Multi-omics in Crohn\u2019s disease: new insights from inside.","volume":"21","author":"Mu","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"R55-20250124","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","article-title":"The gut microbiota is associated with immune cell dynamics in humans.","volume":"588","author":"Schluter","year":"2020","journal-title":"Nature"},{"key":"R56-20250124","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ajg.2016.180","article-title":"Predictors of early failure after fecal microbiota transplantation for the therapy of clostridium difficile infection: a multicenter study.","volume":"111","author":"Fischer","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R57-20250124","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MIB.0000000000000307","article-title":"Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn\u2019s disease.","volume":"21","author":"Suskind","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R58-20250124","doi-asserted-by":"crossref","first-page":"517597","DOI":"10.1155\/2015\/517597","article-title":"Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease.","volume":"2015","author":"Wei","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"R59-20250124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020.","volume":"53","author":"Marcella","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"R60-20250124","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1208\/s12249-020-1637-z","article-title":"The route to palatable fecal microbiota transplantation.","volume":"21","author":"Fadda","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"R61-20250124","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"R62-20250124","doi-asserted-by":"crossref","first-page":"eaap8914","DOI":"10.1126\/scitranslmed.aap8914","article-title":"Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.","volume":"10","author":"Vich","year":"2018","journal-title":"Sci Transl Med"},{"key":"R63-20250124","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/nu14020260","article-title":"Intestinal taxa abundance and diversity in inflammatory bowel disease patients: an analysis including covariates and confounders.","volume":"14","author":"Teofani","year":"2022","journal-title":"Nutrients"},{"key":"R64-20250124","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/gutjnl-2021-326563","article-title":"Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events.","volume":"71","author":"Ng","year":"2022","journal-title":"Gut"},{"key":"R65-20250124","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.3748\/wjg.v28.i40.5801","article-title":"Interaction between gut microbiota and COVID-19 and its vaccines.","volume":"28","author":"Leung","year":"2022","journal-title":"World J Gastroenterol"},{"key":"R66-20250124","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","article-title":"Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review.","volume":"158","author":"Pittayanon","year":"2020","journal-title":"Gastroenterology"},{"key":"R67-20250124","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","article-title":"Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.","volume":"7","author":"Mills","year":"2022","journal-title":"Nat Microbiol"},{"key":"R68-20250124","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/gutjnl-2020-321106","article-title":"Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.","volume":"70","author":"Clooney","year":"2021","journal-title":"Gut"},{"key":"R69-20250124","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/ibd\/izx035","article-title":"Safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease.","volume":"24","author":"Goyal","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R70-20250124","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.3390\/nu6125786","article-title":"Dysbiotic events in gut microbiota: impact on human health.","volume":"6","author":"Schippa","year":"2014","journal-title":"Nutrients"},{"key":"R71-20250124","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrmicro.2017.58","article-title":"The resilience of the intestinal microbiota influences health and disease.","volume":"15","author":"Sommer","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"R72-20250124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13099-019-0341-6","article-title":"Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels.","volume":"12","author":"Alam","year":"2020","journal-title":"Gut Pathog"},{"key":"R73-20250124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases.","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R74-20250124","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1053\/j.gastro.2019.03.017","article-title":"Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases.","volume":"156","author":"Cohen","year":"2019","journal-title":"Gastroenterology"},{"key":"R75-20250124","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation?","volume":"14","author":"Ni","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R76-20250124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000441768","article-title":"Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn\u2019s disease.","volume":"93","author":"Takahashi","year":"2016","journal-title":"Digestion"},{"key":"R77-20250124","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2014.12.006","article-title":"The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.","volume":"149","author":"Cammarota","year":"2015","journal-title":"Pharmacol Ther"},{"key":"R78-20250124","doi-asserted-by":"crossref","first-page":"103062","DOI":"10.1016\/j.jaut.2023.103062","article-title":"Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.","volume":"141","author":"Wu","year":"2023","journal-title":"J Autoimmun"},{"key":"R79-20250124","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation.","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"R80-20250124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1874285801610010057","article-title":"Isolation, detection, and characterization of enterotoxigenic bacteroides fragilis in clinical samples.","volume":"10","author":"Fathi","year":"2016","journal-title":"Open Microbiol J"},{"key":"R81-20250124","doi-asserted-by":"crossref","first-page":"108384","DOI":"10.1016\/j.carres.2021.108384","article-title":"Chemical synthesis of the pentasaccharide repeating unit of the O-specific polysaccharide from Ruminococcus gnavus.","volume":"507","author":"Pal","year":"2021","journal-title":"Carbohydr Res"},{"key":"R82-20250124","doi-asserted-by":"crossref","first-page":"10.1128","DOI":"10.1128\/microbiolspec.AME-0014-2020","article-title":"Distinguishing pathovars from nonpathovars: Escherichia coli.","volume":"8","author":"Riley","year":"2020","journal-title":"Microbiol Spectr"},{"key":"R83-20250124","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gutjnl-2015-311059","article-title":"Comparative genomics of Crohn\u2019s disease-associated adherent-invasive Escherichia coli.","volume":"66","author":"O\u2019Brien","year":"2017","journal-title":"Gut"},{"key":"R84-20250124","doi-asserted-by":"crossref","first-page":"2145729","DOI":"10.1080\/20002297.2022.2145729","article-title":"Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms.","volume":"15","author":"Fan","year":"2023","journal-title":"J Oral Microbiol"},{"key":"R85-20250124","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/JCM.01500-13","article-title":"Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.","volume":"52","author":"Wang","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R86-20250124","doi-asserted-by":"crossref","first-page":"104344","DOI":"10.1016\/j.micpath.2020.104344","article-title":"The critical role of Faecalibacterium prausnitzii in human health: an overview.","volume":"149","author":"Leylabadlo","year":"2020","journal-title":"Microb Pathog"},{"key":"R87-20250124","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jgh.15222","article-title":"Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.","volume":"36","author":"Zhao","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R88-20250124","doi-asserted-by":"crossref","first-page":"872725","DOI":"10.1155\/2014\/872725","article-title":"Association between faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-analysis and systematic review of the literature.","volume":"2014","author":"Cao","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"R89-20250124","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ibd\/izy182","article-title":"Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1.","volume":"24","author":"Zhou","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"R90-20250124","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cyto.2011.08.036","article-title":"TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.","volume":"56","author":"Olsen","year":"2011","journal-title":"Cytokine"},{"key":"R91-20250124","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10620-010-1286-2","article-title":"CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model.","volume":"56","author":"Ogino","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R92-20250124","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1751-2980.2011.00505.x","article-title":"Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease.","volume":"12","author":"Wang","year":"2011","journal-title":"J Dig Dis"},{"key":"R93-20250124","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/MIB.0000000000000477","article-title":"Immunoregulatory pathways involved in inflammatory bowel disease.","volume":"21","author":"Fonseca-Camarillo","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R94-20250124","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","article-title":"Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease.","volume":"65","author":"Quevrain","year":"2016","journal-title":"Gut"},{"key":"R95-20250124","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/1753-0407.12986","article-title":"Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.","volume":"12","author":"Xu","year":"2020","journal-title":"J Diabetes"},{"key":"R96-20250124","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/AEM.69.7.4320-4324.2003","article-title":"Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces.","volume":"69","author":"Hold","year":"2003","journal-title":"Appl Environ Microbiol"},{"key":"R97-20250124","first-page":"1007","article-title":"Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response.","volume":"20","author":"Luo","year":"2019","journal-title":"Mol Med Rep"},{"key":"R98-20250124","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbrc.2018.05.075","article-title":"Roseburia intestinalis-derived flagellin is a negative regulator of intestinal inflammation.","volume":"501","author":"Quan","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"R99-20250124","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3390\/nu14153041","article-title":"Roseburia intestinalis and Its metabolite butyrate inhibit colitis and upregulate TLR5 through the SP3 signaling pathway.","volume":"14","author":"Ruan","year":"2022","journal-title":"Nutrients"},{"key":"R100-20250124","doi-asserted-by":"crossref","first-page":"104285","DOI":"10.1016\/j.ebiom.2022.104285","article-title":"Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn\u2019s disease.","volume":"85","author":"Shen","year":"2022","journal-title":"EBioMedicine"},{"key":"R101-20250124","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1039\/C9BM00980A","article-title":"A new colitis therapy strategy via the target colonization of magnetic nanoparticle-internalized Roseburia intestinalis.","volume":"7","author":"Xiao","year":"2019","journal-title":"Biomater Sci"},{"key":"R102-20250124","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/1751-7915.13410","article-title":"Akkermansia muciniphila is a promising probiotic.","volume":"12","author":"Zhang","year":"2019","journal-title":"Microb Biotechnol"},{"key":"R103-20250124","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","article-title":"Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms.","volume":"19","author":"Cani","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R104-20250124","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4161\/gmic.1.4.12778","article-title":"Mucin-bacterial interactions in the human oral cavity and digestive tract.","volume":"1","author":"Derrien","year":"2010","journal-title":"Gut Microbes"},{"key":"R105-20250124","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R106-20250124","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1038\/emm.2017.282","article-title":"Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions.","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"R107-20250124","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/gutjnl-2017-314508","article-title":"Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice.","volume":"67","author":"Hanninen","year":"2018","journal-title":"Gut"},{"key":"R108-20250124","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/nu14040764","article-title":"Pasteurized Akkermansia muciniphila ameliorate the LPS-induced intestinal barrier dysfunction via modulating AMPK and NF-kappaB through TLR2 in Caco-2 cells.","volume":"14","author":"Shi","year":"2022","journal-title":"Nutrients"},{"key":"R109-20250124","doi-asserted-by":"crossref","first-page":"e76520","DOI":"10.1371\/journal.pone.0076520","article-title":"Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis.","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"key":"R110-20250124","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature07008","article-title":"A microbial symbiosis factor prevents intestinal inflammatory disease.","volume":"453","author":"Mazmanian","year":"2008","journal-title":"Nature"},{"key":"R111-20250124","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.15252\/embr.201642282","article-title":"Strain competition restricts colonization of an enteric pathogen and prevents colitis.","volume":"17","author":"Hecht","year":"2016","journal-title":"EMBO Rep"},{"key":"R112-20250124","doi-asserted-by":"crossref","first-page":"366ra164","DOI":"10.1126\/scitranslmed.aah4669","article-title":"Effects of a gut pathobiont in a gnotobiotic mouse model of childhood undernutrition.","volume":"8","author":"Wagner","year":"2016","journal-title":"Sci Transl Med"},{"key":"R113-20250124","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1472-765X.2012.03229.x","article-title":"Modelling bacterial transmission in human allergen-specific IgE sensitization.","volume":"54","author":"Rudi","year":"2012","journal-title":"Lett Appl Microbiol"},{"key":"R114-20250124","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2021.10.002","article-title":"Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis.","volume":"523","author":"Shao","year":"2021","journal-title":"Cancer Lett"},{"key":"R115-20250124","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","article-title":"Gut microbiota, inflammatory bowel disease and colorectal cancer.","volume":"28","author":"Quaglio","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"Pt 11","key":"R116-20250124","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1242\/jcs.03455","article-title":"Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage.","volume":"120","author":"Wu","year":"2007","journal-title":"J Cell Sci"},{"key":"R117-20250124","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/IAI.00814-08","article-title":"Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL\/6 mice.","volume":"77","author":"Rhee","year":"2009","journal-title":"Infect Immun"},{"key":"R118-20250124","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/biomedicines10040827","article-title":"Bacteroides fragilis toxin induces intestinal epithelial cell secretion of interleukin-8 by the E-cadherin\/beta-catenin\/NF-kappaB dependent pathway.","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"R119-20250124","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s42003-021-02014-3","article-title":"G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis.","volume":"4","author":"Boleij","year":"2021","journal-title":"Commun Biol"},{"key":"R120-20250124","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/gast.2003.50047","article-title":"Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation.","volume":"124","author":"Wu","year":"2003","journal-title":"Gastroenterology"},{"key":"R121-20250124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrmicro818","article-title":"Pathogenic Escherichia coli.","volume":"2","author":"Kaper","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"R122-20250124","doi-asserted-by":"crossref","first-page":"e00060","DOI":"10.1128\/CMR.00060-18","article-title":"Escherichia coli pathobionts associated with inflammatory bowel disease.","volume":"32","author":"Mirsepasi-Lauridsen","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"R123-20250124","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/gutjnl-2021-325971","article-title":"Role of adherent and invasive Escherichia coli in Crohn\u2019s disease: lessons from the postoperative recurrence model.","volume":"72","author":"Buisson","year":"2023","journal-title":"Gut"},{"key":"R124-20250124","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/am.27.5.961-979.1974","article-title":"Human fecal flora: the normal flora of 20 Japanese-Hawaiians.","volume":"27","author":"Moore","year":"1974","journal-title":"Appl Microbiol"},{"key":"R125-20250124","doi-asserted-by":"crossref","first-page":"fuad014","DOI":"10.1093\/femsre\/fuad014","article-title":"Ruminococcus gnavus: friend or foe for human health.","volume":"47","author":"Crost","year":"2023","journal-title":"FEMS Microbiol Rev"},{"key":"R126-20250124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jgh.12727","article-title":"Fecal microbiota transplantation through mid-gut for refractory Crohn\u2019s disease: safety, feasibility, and efficacy trial results.","volume":"30","author":"Cui","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R127-20250124","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/MIB.0000000000000893","article-title":"Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn\u2019s disease.","volume":"22","author":"Vaughn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R128-20250124","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s12325-018-0800-3","article-title":"The Safety of fecal microbiota transplantation for Crohn\u2019s disease: findings from a long-term study.","volume":"35","author":"Wang","year":"2018","journal-title":"Adv Ther"},{"key":"R129-20250124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/5584_2017_123","article-title":"A two-week fecal microbiota transplantation course in pediatric patients with inflammatory bowel disease.","volume":"1047","author":"Karolewska-Bochenek","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"R130-20250124","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/2050640619845986","article-title":"Fecal microbiota transplant for Crohn disease: a study evaluating safety, efficacy, and microbiome profile.","volume":"7","author":"Gutin","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"R131-20250124","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10620-019-05751-y","article-title":"Fecal microbiota transplant via endoscopic delivering through small intestine and colon: no difference for Crohn\u2019s disease.","volume":"65","author":"Yang","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R132-20250124","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1751-7915.13536","article-title":"Efficacy of faecal microbiota transplantation in Crohn\u2019s disease: a new target treatment?","volume":"13","author":"Xiang","year":"2020","journal-title":"Microb Biotechnol"},{"issue":"3","key":"R133-20250124","first-page":"87","article-title":"Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection.","volume":"7","author":"Osaki","year":"2021","journal-title":"Fujita Med J"},{"key":"R134-20250124","doi-asserted-by":"crossref","first-page":"666062","DOI":"10.3389\/fmed.2021.666062","article-title":"Exclusive enteral nutrition plus immediate vs. delayed washed microbiota transplantation in Crohn\u2019s disease with malnutrition: a randomized pilot study.","volume":"8","author":"Xiang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R135-20250124","first-page":"418","article-title":"Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments.","volume":"70","author":"Gottlieb","year":"2021","journal-title":"Gut"},{"key":"R136-20250124","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2036.2006.03184.x","article-title":"Review article: biological activity markers in inflammatory bowel disease.","volume":"25","author":"Desai","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R137-20250124","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/CM9.0000000000000954","article-title":"Nanjing consensus on methodology of washed microbiota transplantation.","volume":"133","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R138-20250124","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","article-title":"Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening.","volume":"11","author":"Zhang","year":"2020","journal-title":"Protein Cell"},{"key":"R139-20250124","doi-asserted-by":"crossref","first-page":"100024","DOI":"10.1016\/j.medmic.2020.100024","article-title":"Washed microbiota transplantation in patients with respiratory spreading diseases: practice recommendations.","volume":"7","author":"Zhang","year":"2021","journal-title":"Med Microecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:01:30Z","timestamp":1737759690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041262","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}